2 months ago
XENE
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Top 15%
#793 out of 5558 analysts
Average Return
+3.4%
Win Rate
45%157 out of 346
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-12 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-10 - 2023-05-09 | Buy |
Cidara Therapeutics IncCDTX | +372.63% | $46.84 | $221.38 | 2025-06-24 - 2026-01-06 | Buy |
Contineum Therapeutics IncCTNM | +260.66% | $3.94 | $14.21 | 2025-05-15 - 2026-05-14 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-23 - 2024-03-06 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
6 months ago
NBIX
9 months ago
NBIX
a year ago
GILD
2 years ago
APLT
3 years ago
DFTX
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings IncCRBP | 10 | Buy | $33.00 | +873.45% | Maintains | 3 days ago |
Definium Therapeutics IncDFTX | 14 | Buy | $70.00 | +118.20% | Maintains | 4 days ago |
Atyr Pharma IncATYR | 3 | Hold | $6.00 | -1.72% | Maintains | 8 days ago |
Sarepta Therapeutics IncSRPT | 33 | Hold | $18.00 | +12.01% | Maintains | 8 days ago |
Acadia Pharmaceuticals IncACAD | 9 | Buy | $38.00 | +102.67% | Maintains | 9 days ago |
Vertex Pharmaceuticals IncVRTX | 61 | Buy | $600.00 | +11.40% | Maintains | 11 days ago |
Neurocrine Biosciences IncNBIX | 30 | Buy | $190.00 | +13.50% | Maintains | 11 days ago |
Regeneron Pharmaceuticals IncREGN | 43 | Hold | $913.00 | -4.44% | Maintains | 12 days ago |
Ptc Therapeutics IncPTCT | 25 | Hold | $77.00 | +21.28% | Maintains | 15 days ago |
Kymera Therapeutics IncKYMR | 4 | Hold | $116.00 | -9.07% | Maintains | 15 days ago |
Incyte CorpINCY | 29 | Hold | $117.00 | -3.28% | Maintains | 15 days ago |
Gilead Sciences IncGILD | 38 | Hold | $131.00 | -22.06% | Maintains | 15 days ago |
Biogen IncBIIB | 47 | Buy | $272.00 | +7.34% | Maintains | 16 days ago |
Nurix Therapeutics IncNRIX | 4 | Buy | $35.00 | +126.10% | Maintains | a month ago |
Aardvark Therapeutics IncAARD | 7 | Hold | $6.00 | +351.13% | Reiterates | 2 months ago |
Lakefront Biotherapeutics NvLKFT | 15 | Buy | $45.00 | +32.43% | Upgrades | 2 months ago |
Xenon Pharmaceuticals IncXENE | 23 | Buy | $70.00 | +72.92% | Maintains | 2 months ago |
Biocryst Pharmaceuticals IncBCRX | 19 | Hold | $11.00 | +44.55% | Downgrades | 2 months ago |
Evommune IncEVMN | 3 | Buy | $21.00 | +175.23% | Maintains | 2 months ago |
Attovia Therapeutics IncATTO | 1 | Buy | $45.00 | +197.42% | Initiates Coverage On | 2 months ago |
Pharvaris NvPHVS | 3 | Buy | $52.00 | +55.88% | Maintains | 3 months ago |
Contineum Therapeutics IncCTNM | 7 | Buy | $23.00 | +133.27% | Maintains | 3 months ago |
Neumora Therapeutics IncNMRA | 8 | Buy | $5.00 | +1,065.50% | Maintains | 4 months ago |
Apogee Therapeutics IncAPGE | 6 | Hold | $135.00 | -0.05% | Maintains | 5 months ago |
Damora Therapeutics IncDMRA | 1 | Buy | $40.00 | +85.19% | Initiates Coverage On | 7 months ago |
Moonlake ImmunotherapeuticsMLTX | 5 | Hold | $13.00 | +4.00% | Maintains | 8 months ago |
Prothena Corp Public Ltd CoPRTA | 13 | Hold | $12.00 | +47.06% | Maintains | 9 months ago |
Gh Research PLCGHRS | 2 | Buy | $40.00 | +109.42% | Maintains | 10 months ago |
Sionna Therapeutics IncSION | 2 | Sell | $24.00 | +620.72% | Downgrades | a year ago |
Pliant Therapeutics IncPLRX | 14 | Hold | $2.00 | N/A | Maintains | a year ago |
Cidara Therapeutics IncCDTX | 2 | Buy | $145.00 | N/A | Maintains | a year ago |
Karyopharm Therapeutics IncKPTI | 12 | Buy | $19.00 | N/A | Maintains | a year ago |
89bio IncETNB | 14 | Hold | $11.00 | N/A | Maintains | a year ago |
Applied Therapeutics IncAPLT | 6 | Hold | $1.50 | N/A | Reiterates | a year ago |
Legend Biotech CorpLEGN | 1 | Buy | $84.00 | N/A | Reiterates | 2 years ago |
Axsome Therapeutics IncAXSM | 2 | Buy | $143.00 | N/A | Maintains | 2 years ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $40.00 | N/A | Reiterates | 2 years ago |
Intra Cellular Therapies IncITCI | 18 | Hold | $132.00 | N/A | Downgrades | 2 years ago |
Igm Biosciences IncIGMS | 15 | Hold | $1.50 | N/A | Downgrades | 2 years ago |
Hookipa Pharma IncHOOK | 11 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Sage Therapeutics IncSAGE | 19 | Hold | $4.00 | N/A | Upgrades | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 8 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | N/A | Maintains | 3 years ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | N/A | Maintains | 3 years ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | N/A | Maintains | 3 years ago |
Ataibeckley IncATAI | 3 | Hold | $9.00 | N/A | Maintains | 5 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 5 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 5 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 6 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 6 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 9 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 9 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.